Why is ANG Lifesciences falling/rising?

As of 05-Sep, ANG Lifesciences India Ltd is currently priced at Rs 25.72, reflecting an increase of Rs 1.22 or 4.98%. Today, the stock opened with a gain of 4.04% and reached an intraday high of Rs 25.72, outperforming its sector by 5.05%. However, despite this short-term gain, the stock has shown significant underperformance over the past year, with a decline of 44.33%. The company has been facing severe financial challenges, reporting operating losses and negative results for the last 12 consecutive quarters, which has contributed to a weak long-term fundamental strength. Additionally, the high debt to EBITDA ratio and the fact that 44.88% of promoter shares are pledged add to the stock's risk profile, exerting downward pressure on its price.
In the broader market context, while ANG Lifesciences has experienced a short-term rise, its one-week performance shows a decline of 3.71%, contrasting with the Sensex, which has gained 1.13% in the same period. This consistent underperformance against the benchmark over the last three years highlights the stock's volatility and investor concerns regarding its financial health. The stock's liquidity appears adequate for trading, but the overall negative sentiment surrounding its operational losses and declining sales suggests that the recent price increase may not be sustainable in the long term.